This topic contains a solution. Click here to go to the answer

Author Question: A patient will begin using a transdermal preparation of a muscarinic antagonist for overactive ... (Read 12 times)

james9437

  • Hero Member
  • *****
  • Posts: 568
A patient will begin using a transdermal preparation of a muscarinic antagonist for overactive bladder (OAB).
 
  The nurse teaches the patient what to do if side effects occur. Which statement by the patient indicates the need for further teaching?
  a. I can use sugar-free gum for dry mouth.
  b. I may need laxatives for constipation.
  c. I should keep the site covered to prevent other people from getting the medicine.
  d. I will take Benadryl for any itching caused by a local reaction to the patch.

Question 2

An older adult patient who lives alone and is somewhat forgetful has an overactive bladder and reports occasional constipation. Which treatment will the nurse anticipate for this patient?
 
  a. Behavioral therapy
  b. Oxybutynin (Ditropan XL) extended-release tablets
  c. Oxybutynin (Oxytrol) transdermal patch
  d. Percutaneous tibial nerve stimulation (PTNS)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

brittiany.barnes

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

ANS: D
Benadryl is an antihistamine, and even though it is not classified as a muscarinic antagonist, it has anticholinergic effects. Giving it with a muscarinic antagonist greatly enhances these effects, so it should not be used. Muscarinic antagonists cause dry mouth, and patients should be taught to use sugar-free gum or candies to help with this. Muscarinic antagonists can cause constipation, and laxatives may be used. Medication applied topically can be transferred to others who come in contact with the skin, so the site should be covered.

Answer to Question 2

ANS: C
The transdermal patch is applied weekly and may be the best option for a patient who is more likely to forget to take a daily medication. The transdermal preparation has fewer side effects than the systemic dose so is less likely to increase this patient's constipation. Behavioral therapy should be tried first in patients who can participate. However, it is not the best option for a forgetful patient who lives alone, because it requires scheduled voiding and timing of fluid intake. The extended-release tablets must be given daily, and this patient may not remember to take them. PTNS is used after behavioral and drug therapies have failed.




james9437

  • Member
  • Posts: 568
Reply 2 on: Jul 23, 2018
Wow, this really help


raili21

  • Member
  • Posts: 324
Reply 3 on: Yesterday
Excellent

 

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

Did you know?

Asthma-like symptoms were first recorded about 3,500 years ago in Egypt. The first manuscript specifically written about asthma was in the year 1190, describing a condition characterized by sudden breathlessness. The treatments listed in this manuscript include chicken soup, herbs, and sexual abstinence.

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

Did you know?

For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.

Did you know?

Anti-aging claims should not ever be believed. There is no supplement, medication, or any other substance that has been proven to slow or stop the aging process.

For a complete list of videos, visit our video library